Video

How Next-Gen Delivery Platforms Are Expanding RNA's Reach

Source: Advancing RNA

Moving RNA delivery beyond LNPs requires biology-led innovation: Nosis Bio’s Jim Martineaux advocates receptor-based targeting for predictable, redosable delivery, while Aegle Therapeutics’ Gloria Matthews highlights exosomes’ natural ability to reach wounds and cross the blood-brain barrier. According to Melissa Bonner, nChroma leverages viral-like particles to expand targeting options, and Nanite Bio’s Sean Kevlahan explains that polymers unlock DNA delivery and in situ protein production, bypassing challenges like AAV re-dosing.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.

Subscribe to Advancing RNA X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Advancing RNA

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)